Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts

Yu X, Zan H, Deng W, He R

OncoTargets and Therapy 2026, 19:606160

Published Date: 19 May 2026